A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable Angina and Multiple Chronic Conditions: LIVEBETTER
To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).
∙ OLDER ADULTS WITH SIHD AND MCC
• Age ≥65 years
• ≥ 2 Multiple Chronic Conditions as defined by Centers for Medicare and Medicaid Services (CMS)
• Diagnosis of Symptomatic Stable Ischemic Heart Disease with plans to initiate medical therapy identified by at least one of the following:
‣ positive non-invasive functional or anatomic testing suggestive of obstructive coronary artery disease
⁃ coronary angiography with stenosis ≥70% in a coronary artery ≥2 mm in diameter or
‣ ≥50% stenosis of left main
⁃ Invasive coronary angiography with positive physiologic testing in at least one vessel (FFR ≤ 0.80 or iFR ≤0.89)
∙ CAREGIVERS
• Age ≥ 18 years
• Identified as caregiver of LIVEBETTER participant